Pharmacokinetic Study of Tenofovir Disoproxil Fumarate Combined with Rifampin in Healthy Volunteers

Tenofovir disoproxil fumarate (tenofovir DF) was studied in combination with rifampin in 24 healthy subjects in a multiple-dose, open-label, single-group, two-period study. All subjects were given tenofovir DF at 300 mg once a day (QD) from days 1 to 10 (period 1). From days 11 to 20 the subjects re...

詳細記述

保存先:
書誌詳細
主要な著者: Droste, J. A. H., Verweij-van Wissen, C. P. W. G. M., Kearney, B. P., Buffels, R., vanHorssen, P. J., Hekster, Y. A., Burger, D. M.
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology 2005
主題:
Antiviral Agents
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC547290/
https://ncbi.nlm.nih.gov/pubmed/15673751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.2.680-684.2005
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料